| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 35 |
| 1 | OXALIPLATIN | 26 |
| 2 | PACLITAXEL | 25 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 25 |
| 4 | CARBOPLATIN | 23 |
| 5 | CAPECITABINE | 22 |
| 6 | FLUOROURACIL | 22 |
| 7 | FLUOROURACIL CREAM, 0.5% | 22 |
| 8 | TRASTUZUMAB | 22 |
| 9 | PREDNISONE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PLATINUM | 1 | 0.0019 |
| 1 | SORBITOL | 1 | 0.0017 |
| 2 | CAPIVASERTIB | 5 | 0.0016 |
| 3 | EPOETIN ALFA-EPBX | 3 | 0.0013 |
| 4 | RAMUCIRUMAB | 8 | 0.0013 |
| 5 | CERITINIB | 3 | 0.0013 |
| 6 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 7 | PANITUMUMAB | 15 | 0.0009 |
| 8 | IMIQUIMOD | 2 | 0.0009 |
| 9 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 8 | 0.0013 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 15 | 0.0003 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 22 | 0.0003 |
| 7 | Cannabinoid [EPC] | 2 | 0.0002 |
| 8 | Estrogen Receptor Antagonist [EPC] | 10 | 0.0002 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |